News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
144,175 Results
Type
Article (14197)
Company Profile (12)
Press Release (129966)
Section
Business (39343)
Career Advice (206)
Deals (5317)
Drug Delivery (16)
Drug Development (18411)
Employer Resources (25)
FDA (2819)
Job Trends (3148)
News (65231)
Policy (5268)
Tag
Academia (1690)
Alliances (12488)
Alzheimer's disease (452)
Approvals (2821)
Artificial intelligence (41)
Bankruptcy (32)
Best Places to Work (2692)
Breast cancer (57)
Cancer (449)
Cardiovascular disease (27)
Career advice (191)
CAR-T (27)
Cell therapy (77)
Clinical research (14030)
Collaboration (152)
COVID-19 (1016)
C-suite (33)
Cystic fibrosis (21)
Data (332)
Diabetes (21)
Diagnostics (1568)
Drug discovery (20)
Earnings (8763)
Employer resources (20)
Events (18371)
Executive appointments (99)
FDA (2974)
Funding (193)
Gene therapy (56)
GLP-1 (98)
Government (1118)
Healthcare (4813)
Infectious disease (1041)
Inflammatory bowel disease (28)
IPO (2694)
Job creations (543)
Job search strategy (182)
Layoffs (40)
Legal (917)
Lung cancer (73)
Lymphoma (28)
Manufacturing (39)
Medical device (2412)
Medtech (2412)
Mergers & acquisitions (2709)
Metabolic disorders (44)
Neuroscience (525)
NextGen: Class of 2025 (1597)
Non-profit (1867)
Northern California (334)
Opinion (45)
Parkinson's disease (22)
People (14940)
Phase I (4765)
Phase II (6460)
Phase III (4234)
Pipeline (112)
Policy (34)
Postmarket research (548)
Preclinical (2175)
Radiopharmaceuticals (46)
Rare diseases (57)
Real estate (1190)
Regulatory (3550)
Research institute (1856)
Series A (35)
Southern California (293)
Startups (1060)
United States (3294)
Vaccines (180)
Date
Today (36)
Last 7 days (76)
Last 30 days (342)
Last 365 days (7091)
2025 (318)
2024 (7200)
2023 (8688)
2022 (11529)
2021 (12830)
2020 (12164)
2019 (10917)
2018 (8076)
2017 (7339)
2016 (7426)
2015 (8708)
2014 (6450)
2013 (5318)
2012 (5394)
2011 (5629)
2010 (4802)
Location
Africa (187)
Alabama (25)
Arizona (39)
Asia (9103)
Australia (2028)
California (754)
Canada (272)
China (54)
Colorado (40)
Connecticut (36)
Delaware (26)
Europe (18858)
Florida (150)
Illinois (99)
Indiana (36)
Japan (24)
Maryland (123)
Massachusetts (570)
Minnesota (57)
New Jersey (325)
New York (259)
North Carolina (134)
Northern California (334)
Ohio (37)
Pennsylvania (173)
South America (246)
Southern California (293)
Texas (170)
Washington D.C. (25)
Washington State (98)
144,175 Results for "salk institute".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Beach
Trailblazing work with 3D Human Liver Models Yields Accurate MASH (formerly NASH) Phenotype
Viscient Biosciences announced that its scientists, along with collaborators from University of California, San Diego, Sanford-Burnham-Prebys medical research institute, and Salk Institute, have published the first demonstration of a liver fibrosis phenotype in a 3D human tissue model of MASH demonstrating strong comparability to the native disease by multiple measures.
January 23, 2024
·
5 min read
Pharm Country
Renal Research Institute and Karolinska Institutet announce chronic kidney disease management symposium, highlighting new therapeutics
Renal Research Institute, a global leader in dialysis and nephrology research and a subsidiary of Fresenius Medical Care AG, announced together with the Karolinska Institutet a joint symposium, “Prevention of CKD progression: the impact of new therapeutics.” The Karolinska Institutet is one of the world’s leading medical universities.
May 17, 2024
·
3 min read
Press Releases
Quantum Computing, Inc. Announces Collaboration with Sanders Tri-Institutional Therapeutics Discovery Institute To Support Research Using Dirac-3 Systems
January 15, 2025
·
4 min read
Immutep successfully completes institutional placement and institutional component of entitlement offer
Immutep Limited ACN 009 237 889 is pleased to announce the successful completion of its institutional placement and the institutional component of its 1 for 16 pro rata accelerated non-renounceable entitlement offer of new fully paid ordinary shares in Immutep.
June 5, 2024
·
7 min read
Press Releases
Guardant Health Shield Platform Selected for Inclusion in National Cancer Institute’s Vanguard Study to Evaluate Emerging Technologies for Multi-Cancer Detection
January 7, 2025
·
4 min read
Press Releases
ClearNote Health’s Avantect® Multi-Cancer Detection Test Selected as One of Two Noninvasive Blood-Based Technologies for National Cancer Institute’s Vanguard Study
January 7, 2025
·
3 min read
BioForest
Pacific Northwest Research Institute Uncovers Hidden DNA Mechanisms of Rare Genetic Diseases
Researchers at the Pacific Northwest Research Institute (PNRI) and collaborating institutions have made a groundbreaking discovery that could significantly advance our understanding of genomic disorders.
June 21, 2024
·
3 min read
Pharm Country
PAVmed Subsidiary, Veris Health, Announces Launch of Pilot Program with The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
PAVmed Inc announced that Veris and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, a National Cancer Institute-Designated Comprehensive Cancer Center, launched a pilot program and enrolled the first patients on the Veris Cancer Care Platform™ pursuant to a recently-executed memorandum of understanding.
June 13, 2024
·
5 min read
Business
The Foundation for the National Institutes of Health Names Recipients of the 2024 Charles A. Sanders, MD, Partnership Award
The Foundation for the National Institutes of Health will award the 2024 Charles A. Sanders, MD, Partnership Award to the National Institutes of Health’s National Institute of Neurological Disorders and Stroke, AbbVie, and Robert and Sarah Newcomb.
June 18, 2024
·
4 min read
Business
Salk Institute and BridgeBio Pharma Collaborate to Advance Therapies for Genetically Driven Disease
The Salk Institute and BridgeBio Pharma, Inc. (Nasdaq: BBIO) today announced a three-year collaboration agreement formed to advance cutting-edge academic discoveries in genetically driven diseases toward therapeutic applications.
October 21, 2020
·
5 min read
1 of 14,418
Next
